Float Tank Safety Profile: Adverse Events Reported

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Floatation-REST has shown no serious adverse events in multiple trials involving individuals with anxiety, depression, and anorexia nervosa.
A 2024 study with 75 participants found 85% adherence for weekly 1-hour float sessions and 89% for flexible float sessions.
Positive experiences were more common and rated higher than negative ones in a 2024 trial of floatation-REST for anxious and depressed individuals.
Limited evidence suggests potential benefits for anxiety, muscle tension, blood pressure, and sleep difficulties, with an acute anxiolytic and antidepressant effect lasting over 48 hours.

Floatation-REST, or Reduced Environmental Stimulation Therapy via floatation, is a method designed to lessen external sensory input to the nervous system. Our analysis of recent studies shows that this intervention generally has a favorable safety profile. Multiple randomized controlled trials have reported no serious adverse events linked to floatation therapy across various populations. For instance, a 2024 randomized controlled trial involving 75 individuals with anxiety and depression found no serious adverse events associated with any intervention, including floatation-REST. This trial also revealed that positive experiences were endorsed more commonly than negative ones, and these positive experiences were rated at higher levels of intensity by participants. This suggests floatation-REST is not only safe but also well-tolerated.

Is Floatation-REST Safe for Mental Health Conditions?

Yes, floatation-REST appears to be safe for individuals dealing with mental health conditions. Multiple randomized controlled trials have consistently reported no serious adverse events associated with this therapy. This finding holds true for studies involving participants with conditions like anxiety, depression, and even anorexia nervosa.

Safety in Anxiety and Depression Trials

A significant 2024 randomized controlled safety and feasibility trial looked at floatation-REST in individuals experiencing anxiety and depression Safety and feasibility of floatation-REST in anxious and depressed individuals. This study included 75 participants who were randomized into different floatation-REST formats or an active comparator group. The researchers reported that there were no serious adverse events linked to any of the interventions tested. This outcome is crucial for understanding the safety profile of floatation therapy when used as a repeated intervention in these vulnerable populations. The study confirms earlier findings that single sessions of floatation-REST are safe and well-tolerated.

The participants in this 2024 trial showed good adherence to the floatation protocols. For those assigned to weekly 1-hour float sessions, the adherence rate was 85%, with participants completing an average of 5.1 sessions out of six planned. For individuals in the "pool-REST preferred" group, who had flexibility in session duration and frequency, adherence was even higher at 89%, with an average of 5.3 sessions completed. The average duration for weekly pool-REST sessions was 53.0 minutes, while the flexible sessions averaged 75.4 minutes. These high adherence rates, combined with the absence of serious adverse events, highlight the therapy's overall safety and tolerability.

Safety in Anorexia Nervosa Research

Beyond anxiety and depression, floatation-REST has also been investigated for its potential benefits in other psychiatric disorders. A randomized clinical efficacy trial published in 2023 examined the impact of floatation therapy on body image disturbance and anxiety in inpatients with anorexia nervosa (AN) https://pubmed.ncbi.nlm.nih.gov/37936658/. While the primary focus of this study was efficacy, the fact that it proceeded as a clinical trial for a population with a complex disorder like AN, which has one of the highest mortality rates among psychiatric disorders, further supports the general safety of the intervention. The study design implies that researchers deemed floatation-REST safe enough to be tested in such a sensitive group, although specific adverse event data from this particular trial were not detailed in the provided research.

Overall Tolerability and Participant Experience

Across studies, the general experience reported by participants undergoing floatation-REST tends to be positive. In the 2024 trial for anxious and depressed individuals, positive experiences were endorsed more commonly than negative ones. Not only were they more frequent, but participants also rated these positive experiences at higher levels of intensity. This suggests that beyond just being safe, floatation therapy is generally perceived as a pleasant and beneficial experience by those who try it. The lack of serious adverse events, coupled with positive participant feedback, reinforces the idea that floatation-REST is a low-risk intervention for mental health support. The overall picture points to floatation-REST as a safe and well-received therapeutic option, particularly for managing symptoms associated with anxiety and depression.

What About Floatation Therapy for Chronic Pain?

Floatation-REST has been investigated as a treatment for chronic pain, with research exploring its potential to alleviate discomfort and improve quality of life for individuals suffering from long-term pain conditions. This therapy aims to reduce sensory input, which can help calm the nervous system and potentially interrupt pain signals. Studies have specifically looked at its impact on conditions like fibromyalgia, a chronic widespread pain condition.

Research into Chronic Pain Relief

One randomized clinical trial focused on floatation Restricted Environmental Stimulation Therapy for chronic pain Floatation-REST for chronic pain trial. This study included a total of 99 participants, divided into an intervention group, a placebo group, and a wait-list control group. The intervention group, which received floatation therapy, consisted of 32 participants. In this specific group, 84% were women, and the average age was 52.8 years. The demographic data shows that chronic pain affects a diverse population, and studies like this are important for understanding how different groups respond to floatation therapy.

The rationale behind using floatation therapy for chronic pain is rooted in its ability to create an environment free from external stimuli. This can lead to deep relaxation, which may help reduce muscle tension and the perception of pain. While specific outcomes regarding adverse events from this chronic pain trial were not explicitly detailed in the provided research, the conduct of a randomized clinical trial for chronic pain itself indicates that the therapy was considered safe enough for investigation in this population. The study's design focused on evaluating the therapy's efficacy for chronic pain, suggesting an underlying assumption of its safety profile.

Fibromyalgia and Floatation Therapy

Fibromyalgia is a condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues. People with fibromyalgia often feel trapped by their physical experience of chronic pain. Floatation therapy has been explored as a potential aid for this condition, with some suggesting it can help "END PAIN" for those with fibromyalgia https://www.clinicalfloat.org/floating-to-help-fibromyalgia. The unique environment of a float tank, where the body is suspended effortlessly in a warm, saline solution, can provide relief from gravitational pressure on joints and muscles, which is particularly beneficial for individuals experiencing constant pain.

While the provided research highlights the interest in floatation therapy for fibromyalgia, it does not offer specific statistics on adverse events from studies directly focused on this condition. However, the general safety profile of floatation-REST, as observed in trials for mental health conditions, provides a broader context. The consistent reporting of no serious adverse events in other populations suggests that floatation therapy is likely also safe for individuals with chronic pain conditions like fibromyalgia, making it a viable non-pharmacological option for consideration. The ongoing research in this area aims to further quantify the benefits and ensure continued safety for this patient group.

Are There Any Negative Side Effects Reported?

Reviews of floatation therapy trials for mental health conditions have consistently found no reports of serious adverse events or negative side effects. Participants in these studies commonly reported positive experiences, indicating a high level of tolerability for the therapy. This suggests that floatation-REST is a generally well-received and low-risk intervention.

Absence of Serious Adverse Events

Across multiple randomized controlled trials and systematic reviews, the safety of floatation therapy has been a key area of investigation. For instance, a review of floatation therapy for mental health conditions explicitly stated, "Both trials reported no serious adverse events or negative side effects associated with the floatation therapy" https://www.ncbi.nlm.nih.gov/books/NBK594333/. This finding is critical because it addresses one of the primary concerns when introducing any new therapeutic intervention. The absence of serious adverse events suggests that floatation-REST does not pose significant health risks to participants when administered under controlled study conditions.

The 2024 trial involving 75 individuals with anxiety and depression further supports this. This study initially screened 1,715 individuals before randomizing the final participants, demonstrating a rigorous selection process. Despite the large initial pool and the focus on individuals with existing mental health challenges, the trial concluded with no serious adverse events associated with any of the floatation interventions. This robust finding reinforces the safety profile of floatation-REST even for those with pre-existing vulnerabilities.

High Tolerability and Positive Experiences

Beyond the absence of serious adverse events, the overall tolerability of floatation-REST appears high. In the 2024 trial, positive experiences were endorsed more commonly than negative ones, and these positive experiences were also rated at higher levels of intensity by the participants. This indicates that not only is the therapy safe, but it is also generally pleasant and perceived as beneficial by those undergoing it.

Dropout rates are another indicator of tolerability. In the 2024 study, dropout rates at the end of the intervention did not differ significantly between the various treatment conditions, including the floatation-REST groups and the active comparator (chair-REST) group. This suggests that participants found the floatation sessions manageable and were not significantly deterred by any discomfort or negative experiences. The mean session durations were also quite consistent, with weekly float sessions lasting 53.0 minutes and flexible sessions lasting 75.4 minutes, further indicating that participants were comfortable staying in the float tanks for extended periods. The consistent reporting of positive experiences and low dropout rates, coupled with the absence of serious adverse events, paints a clear picture of floatation therapy as a safe and well-tolerated option for various health conditions.

How Does Floatation-REST Compare to Other Treatments?

Floatation-REST has been compared to other treatments in some trials to understand its relative efficacy and tolerability. Some studies have utilized active comparators, such as chair-REST, which involves weekly sessions in a Zero Gravity chair. This comparison helps researchers determine if the unique aspects of floatation therapy, specifically the reduced environmental stimulation, offer distinct advantages over other relaxation techniques. Floatation-REST is fundamentally designed to attenuate exteroceptive sensory input to the nervous system, which is a different mechanism from simply sitting in a comfortable chair.

Comparison with Chair-REST

In the 2024 randomized controlled safety and feasibility trial for anxious and depressed individuals, one of the intervention arms was an active comparator group known as "chair-REST." This group completed weekly 1-hour sessions in a Zero Gravity chair. This allowed for a direct comparison of adherence and tolerability between a sensory-reducing environment (floatation) and a comfortable, but still sensory-rich, environment (Zero Gravity chair).

When comparing the adherence rates, floatation-REST showed superior engagement. Adherence for pool-REST (weekly 1-hour float sessions) was 85%, with participants completing an average of 5.1 sessions. For pool-REST preferred (flexible float sessions), adherence was even higher at 89%, with an average of 5.3 sessions. In contrast, adherence for the chair-REST group was 74%, with participants completing an average of 4.4 sessions out of six planned. The mean session duration for chair-REST was 58.4 minutes, which was slightly longer than the fixed 1-hour float sessions but shorter than the flexible float sessions. These numbers indicate that participants were more likely to complete their assigned sessions when undergoing floatation-REST compared to chair-REST. This difference in adherence suggests that floatation therapy might be more engaging or perceived as more beneficial, leading to higher retention rates.

The Mechanism of Reduced Environmental Stimulation

The core principle behind floatation-REST is the attenuation of exteroceptive sensory input to the nervous system. This means significantly reducing external stimuli like light, sound, and gravity. In a float tank, the water is heated to skin temperature, minimizing thermal sensation, and the high concentration of Epsom salts makes the body effortlessly buoyant, eliminating gravitational pressure. This creates a unique environment that is difficult to replicate with other relaxation methods.

While a Zero Gravity chair can offer comfort and a degree of physical relaxation, it does not achieve the profound level of sensory reduction that floatation-REST does. The chair-REST environment still allows for significant visual and auditory input, and the body still experiences the sensation of touch and pressure from the chair itself. The higher adherence rates for floatation-REST in the 2024 study could be attributed to the unique and profound relaxation experienced in a float tank, which may be more appealing or effective for individuals seeking relief from anxiety and depression. This comparison underscores the distinct nature of floatation-REST as an intervention primarily focused on sensory attenuation, setting it apart from more conventional relaxation techniques.

What Benefits Might Float Therapy Offer?

Float therapy, also known as floatation-REST, offers several potential benefits, particularly for individuals struggling with mental health challenges and certain physical conditions. The unique environment of a float tank, designed to minimize external sensory input, can lead to deep relaxation and physiological changes that contribute to these benefits.

Mental Health Improvements

Limited evidence from randomized controlled trials suggests that floatation with restricted environmental stimulation therapy may provide potential benefits in reducing anxiety and improving many of the symptoms associated with anxiety. This includes a range of related issues such as muscle tension, elevated blood pressure, difficulties in emotion regulation, sleep difficulties, and even symptoms of depression https://www.ncbi.nlm.nih.gov/books/NBK594333/. The reduction of external stimuli allows the mind to quiet down, which can be particularly helpful for individuals whose anxiety is fueled by overthinking or hyper-awareness of their surroundings.

Furthermore, prior studies in anxious and depressed individuals have demonstrated that single sessions of floatation-REST are associated with an acute anxiolytic (anxiety-reducing) and antidepressant effect. This positive effect can persist for over 48 hours, as noted by McKenna M Garland et al. in their 2024 PLoS One publication. This means that even a single float session can provide significant and lasting relief from symptoms of anxiety and depression, suggesting its potential as a short-term intervention or a complementary therapy. The ability to achieve such an effect without pharmacological intervention is a significant advantage for many individuals seeking alternative or adjunct treatments.

Physical and Physiological Benefits

Beyond mental health, the sensory deprivation environment of a float tank can also lead to various physical and physiological improvements. The effortless buoyancy in the high-salinity water relieves pressure on joints, muscles, and the spine, which can be particularly beneficial for individuals experiencing chronic pain or muscle tension. This physical relief contributes to the overall relaxation response.

The reduction in muscle tension is a direct benefit often reported by users and is logically linked to the weightless environment. Similarly, the deep relaxation induced by floatation-REST can lead to a reduction in blood pressure, as the body's fight-or-flight response is suppressed. Improved sleep quality is another commonly reported benefit, likely due to the profound relaxation and reduction in anxiety achieved during a float session. By addressing these interconnected physical and mental symptoms, floatation therapy offers a holistic approach to wellness, providing relief across multiple domains of health.

Broader Applications

The research also indicates that floatation-REST has been explored for conditions like anorexia nervosa, where body image disturbance and anxiety are core features https://pubmed.ncbi.nlm.nih.gov/37936658/. While the specific benefits for AN were not detailed in the provided research, the investigation into such complex disorders underscores the potential breadth of float therapy's applications. The calming and body-neutral environment of a float tank could theoretically provide a safe space for individuals to process their thoughts and feelings without external judgment or sensory triggers related to body image. As research continues, we may uncover even more specific benefits and applications for floatation therapy across a wider range of physical and mental health conditions.

Is Floatation Therapy Cost-Effective or Widely Recommended?

Currently, there is limited information regarding the cost-effectiveness of floatation therapy for mental health conditions, and no widespread evidence-based guidelines with recommendations for its use have been identified. While the safety and potential benefits are increasingly recognized, more research is needed to establish its economic viability and to integrate it into standard clinical practice.

Lack of Cost-Effectiveness Data

One of the key messages from a review on floatation therapy for mental health conditions is that "No evidence was found on the cost-effectiveness of floatation therapy for the treatment of mental health conditions" https://www.ncbi.nlm.nih.gov/books/NBK594333/. This means that while studies have focused on the safety and efficacy of the therapy, there hasn't been enough research to determine if it provides a good return on investment compared to other treatments. Cost-effectiveness analyses are crucial for healthcare systems and insurance providers to decide whether to cover a treatment. Without this data, it remains challenging for floatation therapy to be widely adopted as a standard, reimbursable medical intervention.

Understanding cost-effectiveness involves comparing the cost of the therapy with the health outcomes it produces, often against alternative treatments. For instance, if floatation therapy can significantly reduce the need for medication or other more expensive interventions, it might be deemed cost-effective. However, this type of economic analysis is complex and requires dedicated studies. The absence of such evidence does not mean floatation therapy is not cost-effective, but rather that the research to prove it has not yet been conducted or published in a conclusive manner.

Absence of Evidence-Based Guidelines

Similarly, the same review noted, "No evidence-based guidelines with recommendations regarding the use of floatation therapy for the treatment of mental health conditions were identified." Evidence-based guidelines are formal recommendations developed by expert panels based on a thorough review of scientific evidence. These guidelines help healthcare professionals make informed decisions about patient care. The lack of such guidelines for floatation therapy means that its application for mental health conditions is not yet standardized across the medical community.

This situation is common for emerging therapies or those considered complementary and alternative medicine. For a therapy to be included in official guidelines, a substantial body of evidence demonstrating consistent efficacy, safety, and often cost-effectiveness is usually required. While individual studies show promising results for floatation-REST, particularly in reducing anxiety and depression symptoms, this has not yet translated into broad clinical recommendations.

Future Directions for Research and Integration

The path to wider acceptance and integration into mainstream healthcare for floatation therapy will likely involve more extensive research. This includes larger randomized controlled trials, studies specifically designed to assess cost-effectiveness, and real-world implementation studies. As McKenna M Garland et al. noted in 2024, "Prior studies in anxious and depressed individuals demonstrated that single sessions of floatation-REST are safe, well-tolerated, and associated with an acute anxiolytic and antidepressant effect that persists for over 48 hours." This foundational work on safety and initial efficacy is a strong starting point.

However, to move from promising results to widespread recommendations, more comprehensive data is needed. This would help establish clear protocols for its use, identify specific patient populations who benefit most, and determine its place within a broader treatment landscape. Until then, floatation therapy remains a beneficial, safe, and well-tolerated option that individuals can explore, but it operates outside the realm of widely endorsed, evidence-based clinical guidelines for mental health treatment.

Frequently Asked Questions

Has float therapy been tested in clinical trials?

Yes, float therapy, or floatation-REST, has been tested in multiple clinical trials. For example, a 2024 randomized controlled trial included 75 individuals with anxiety and depression to assess its safety and feasibility https://pubmed.ncbi.nlm.nih.gov/38843272. Other trials have investigated its effects on chronic pain and even anorexia nervosa.

What kind of adverse events are typically reported with floatation-REST?

Clinical trials on floatation-REST have consistently reported no serious adverse events. For instance, the 2024 trial with anxious and depressed individuals found no serious adverse events associated with any intervention. Reviews of mental health trials also confirmed no serious adverse events or negative side effects. Participants more commonly report positive experiences than negative ones.

Can floatation therapy help with anxiety and depression?

Yes, limited evidence suggests floatation therapy may help reduce anxiety and improve symptoms associated with it, including muscle tension, blood pressure, emotion regulation difficulties, sleep issues, and depression. Single sessions have been shown to have an acute anxiolytic and antidepressant effect that persists for over 48 hours.

Is float therapy effective for chronic pain conditions like fibromyalgia?

Research has investigated floatation-REST for chronic pain. A randomized clinical trial on chronic pain included 32 participants in the intervention group, with 84% being women and an average age of 52.8 years https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871. While specific efficacy data from this trial for fibromyalgia was not detailed in the provided research, the therapy's ability to reduce sensory input and provide physical relief makes it a promising area for chronic pain management.

Are there official guidelines for using float therapy in mental health treatment?

Currently, no evidence-based guidelines with recommendations regarding the use of floatation therapy for the treatment of mental health conditions have been identified. Additionally, there is no evidence on its cost-effectiveness. More research is needed before it can be widely recommended in official clinical guidelines.